{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:44:37Z","timestamp":1792759477543,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T00:00:00Z","timestamp":1578528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000058","name":"Substance Abuse and Mental Health Services Administration","doi-asserted-by":"publisher","award":["1H79SP022117"],"award-info":[{"award-number":["1H79SP022117"]}],"id":[{"id":"10.13039\/100000058","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In response to the opioid epidemic, naloxone distribution programs aim to prevent overdose death by making naloxone available and training people to use it. Peers of individuals at risk of opioid overdose are well-positioned to administer naloxone and prevent overdose death.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted key informant interviews with 18 individuals with past or current opioid and heroin drug use who had administered naloxone to a peer during an overdose emergency. Interviews explored individuals\u2019 experiences with administration and their recommendations for program and policy improvement. Data were systematically coded and analyzed for themes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Participants sought naloxone rescue kits because they perceived high risk of overdose. They described high satisfaction with training and felt prepared to administer naloxone during overdose incidents. Overwhelmingly, participants perceived naloxone to be effective and emphasized the need to make it widely available. Findings suggest that engagement in overdose prevention strategies other than naloxone differs by gender, with females more likely than males to use multiple different strategies. Participants described that overdose experiences do not have a lasting impact on drug use behaviors.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Findings support the feasibility of naloxone distribution to peer opioid and heroin users and provide recommendations for policy improvement, including effective and well-advertised Good Samaritan laws and links to treatment for opioid use disorder.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12954-019-0352-0","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T16:02:27Z","timestamp":1578585747000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Preventing opioid overdose with peer-administered naloxone: findings from a rural state"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8441-8601","authenticated-orcid":false,"given":"Bridget L.","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca R.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Z\u00f6ld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Terhorst-Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,9]]},"reference":[{"issue":"6","key":"352_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.24095\/hpcdp.38.6.02","volume":"38","author":"L Belzak","year":"2018","unstructured":"Belzak L, Halverson J. The opioid crisis in Canada: a national perspective. Heal Promot Chron Dis Prev Can. 2018;38(6):224\u201333.","journal-title":"Heal Promot Chron Dis Prev Can"},{"issue":"1","key":"352_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/bcp.13792","volume":"85","author":"S Lalic","year":"2019","unstructured":"Lalic S, Ilom\u00e4ki J, Bell JS, Korhonen MJ, Gisev N. Prevalence and incidence of prescription opioid analgesic use in Australia. Br J Clin Pharmacol. 2019;85(1):202\u201315.","journal-title":"Br J Clin Pharmacol"},{"key":"352_CR3","volume-title":"Opioid overdose crisis","author":"National Institute on Drug Abuse","year":"2019","unstructured":"National Institute on Drug Abuse. Opioid overdose crisis. 2019. Available from: https:\/\/www.drugabuse.gov\/drugs-abuse\/opioids\/opioid-overdose-crisis."},{"key":"352_CR4","volume-title":"Europe\u2019s silent opioid epidemic","author":"G Finnegan","year":"2018","unstructured":"Finnegan G. Europe\u2019s silent opioid epidemic. Vancouver: Horizon; 2018. Available from: https:\/\/horizon-magazine.eu\/article\/europes-silent-opioid-epidemic.html"},{"key":"352_CR5","unstructured":"Gebelhoff R. The opioid epidemic could turn into a pandemic if we\u2019re not careful. The Washington post: Washington, D.C.. 2017; Available from: https:\/\/www.washingtonpost.com\/news\/in-theory\/wp\/2017\/02\/09\/the-opioid-epidemic-could-turn-into-a-pandemic-if-were-not-careful\/."},{"issue":"10134","key":"352_CR6","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1016\/S0140-6736(18)31073-0","volume":"391","author":"L Salm-Reifferscheidt","year":"2018","unstructured":"Salm-Reifferscheidt L. Tramadol: Africa\u2019s opioid crisis. Lancet. 2018;391(10134):1982\u20133.","journal-title":"Lancet."},{"issue":"4","key":"352_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.2105\/AJPH.2017.304265","volume":"108","author":"P Seth","year":"2018","unstructured":"Seth P, Rudd RA, Noonan RK, Haegerich TM. Quantifying the epidemic of prescription opioid overdose deaths. Am J Public Health. 2018;108(4):500\u20132.","journal-title":"Am J Public Health"},{"issue":"2","key":"352_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s11904-018-0390-3","volume":"15","author":"DC Perlman","year":"2018","unstructured":"Perlman DC, Jordan AE. The syndemic of opioid misuse, overdose, HCV, and HIV: structural-level causes and interventions. Curr HIV\/AIDS Rep. 2018;15(2):96\u2013112.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"6","key":"352_CR9","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1007\/s11524-010-9495-8","volume":"87","author":"L Enteen","year":"2010","unstructured":"Enteen L, Bauer J, McLean R, Wheeler E, Huriaux E, Kral AH, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health. 2010;87(6):931\u201341.","journal-title":"J Urban Health"},{"key":"352_CR10","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.drugpo.2017.06.005","volume":"46","author":"N Fairbairn","year":"2017","unstructured":"Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172\u20139.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"352_CR11","first-page":"235","volume":"88","author":"KF Hawk","year":"2015","unstructured":"Hawk KF, Vaca FE, D\u2019Onofrio G. Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies. Yale J Biol Med. 2015;88(3):235\u201345.","journal-title":"Yale J Biol Med"},{"issue":"4","key":"352_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3109\/09687637.2012.658104","volume":"19","author":"T Bennett","year":"2012","unstructured":"Bennett T, Holloway K. The impact of take-home naloxone distribution and training on opiate overdose knowledge and response: an evaluation of the THN Project in Wales. Drugs Educ Prev Policy. 2012;19(4):320\u20138.","journal-title":"Drugs Educ Prev Policy"},{"issue":"8","key":"352_CR13","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1080\/15564886.2018.1514552","volume":"13","author":"AJ Lurigio","year":"2018","unstructured":"Lurigio AJ, Andrus J, Scott CK. The opioid epidemic and the role of law enforcement officers in saving lives. Vict Offenders. 2018;13(8):1055\u201376.","journal-title":"Vict Offenders"},{"key":"352_CR14","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.drugpo.2019.01.006","volume":"71","author":"M Karamouzian","year":"2019","unstructured":"Karamouzian M, Kuo M, Crabtree A, Buxton JA. Correlates of seeking emergency medical help in the event of an overdose in British Columbia, Canada: findings from the Take Home Naloxone program. Int J Drug Policy. 2019;71:157\u201363.","journal-title":"Int J Drug Policy"},{"key":"352_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.drugpo.2017.06.008","volume":"48","author":"S Koester","year":"2017","unstructured":"Koester S, Mueller SR, Raville L, Langegger S, Binswanger IA. Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose? Int J Drug Policy. 2017;48:115\u201324.","journal-title":"Int J Drug Policy"},{"key":"352_CR16","doi-asserted-by":"publisher","first-page":"107555","DOI":"10.1016\/j.drugalcdep.2019.107555","volume":"204","author":"E Saunders","year":"2019","unstructured":"Saunders E, Metcalf SA, Walsh O, Moore SK, Meier A, McLeman B, et al. \u201cYou can see those concentric rings going out\u201d: emergency personnel\u2019s experiences treating overdose and perspectives on policy-level responses to the opioid crisis in New Hampshire. Drug Alcohol Depend. 2019;204:107555.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"352_CR17","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/10826080701801261","volume":"43","author":"TM Piper","year":"2008","unstructured":"Piper TM, Stancliff S, Rudenstine S, Sherman S, Nandi V, Clear A, et al. Evaluation of a naloxone distribution and administration program in New York City. Subst Use Misuse. 2008;43(7):858\u201370.","journal-title":"Subst Use Misuse"},{"issue":"2","key":"352_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/jurban\/jti053","volume":"82","author":"KH Seal","year":"2005","unstructured":"Seal KH, Thawley R, Gee L, Bamberger J, Kral AH, Ciccarone D, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: a pilot intervention study. J Urban Health. 2005;82(2):303\u201311.","journal-title":"J Urban Health"},{"issue":"2","key":"352_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.drugpo.2008.03.002","volume":"20","author":"KE Tobin","year":"2009","unstructured":"Tobin KE, Sherman SG, Beilenson P, Welsh C, Latkin CA. Evaluation of the Staying Alive programme: training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20(2):131\u20136.","journal-title":"Int J Drug Policy"},{"issue":"7","key":"352_CR20","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1592\/phco.30.7.627","volume":"30","author":"DP Wermeling","year":"2010","unstructured":"Wermeling DP. Opioid harm reduction strategies: focus on expanded access to intranasal naloxone. Pharmacotherapy. 2010;30(7):627\u201331.","journal-title":"Pharmacotherapy."},{"issue":"3","key":"352_CR21","first-page":"531","volume":"35","author":"M Mahoney","year":"2018","unstructured":"Mahoney M. The global opioid crisis: effective laws to fight rising overdose fatalities through access to naloxone. Ariz J Int Comp Law. 2018;35(3):531\u201357.","journal-title":"Ariz J Int Comp Law"},{"key":"352_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1477-7517-4-3","volume":"4","author":"TM Piper","year":"2007","unstructured":"Piper TM, Rudenstine S, Stancliff S, Sherman S, Nandi V, Clear A, et al. Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City. Harm Reduct J. 2007;4:3.","journal-title":"Harm Reduct J"},{"key":"352_CR23","first-page":"5","volume":"24","author":"SG Sherman","year":"2008","unstructured":"Sherman SG, Gann DS, Scott G, Carlberg S, Bigg D, Heimer R. A qualitative study of overdose responses among Chicago IDUs. Harm Reduct J. 2008;24:5.","journal-title":"Harm Reduct J"},{"issue":"3","key":"352_CR24","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1300\/J069v25n03_11","volume":"25","author":"S Maxwell","year":"2006","unstructured":"Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89\u201396.","journal-title":"J Addict Dis"},{"issue":"5","key":"352_CR25","doi-asserted-by":"publisher","first-page":"788","DOI":"10.2105\/AJPH.2008.146647","volume":"99","author":"M Doe-Simkins","year":"2009","unstructured":"Doe-Simkins M, Walley AY, Epstein A, Moyer P. Saved by the nose: bystander-administered intranasal naloxone hydrochloride for opioid overdose. Am J Public Health. 2009;99(5):788\u201391.","journal-title":"Am J Public Health"},{"key":"352_CR26","first-page":"346(7894)","volume":"9","author":"AY Walley","year":"2013","unstructured":"Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;9:346(7894).","journal-title":"BMJ."},{"key":"352_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.drugpo.2018.02.008","volume":"55","author":"C Keane","year":"2018","unstructured":"Keane C, Egan JE, Hawk M. Effects of naloxone distribution to likely bystanders: results of an agent-based model. Int J Drug Policy. 2018;55:61\u20139.","journal-title":"Int J Drug Policy"},{"issue":"6","key":"352_CR28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/j.1360-0443.2008.02182.x","volume":"103","author":"TC Green","year":"2008","unstructured":"Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction. 2008;103(6):979\u201389.","journal-title":"Addiction."},{"issue":"7","key":"352_CR29","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.2105\/AJPH.2016.303141","volume":"106","author":"DA Lewis","year":"2016","unstructured":"Lewis DA, Park JN, Vail L, Sine M, Welsh C, Sherman SG. Evaluation of the overdose education and naloxone distribution program of the Baltimore Student Harm Reduction Coalition. Am J Public Health. 2016;106(7):1243\u20136.","journal-title":"Am J Public Health"},{"issue":"4","key":"352_CR30","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3109\/09687630802530712","volume":"17","author":"A McAuley","year":"2010","unstructured":"McAuley A, Lindsay G, Woods M, Louttit D. Responsible management and use of a personal take-home naloxone supply: a pilot project. Drugs Educ Prev Policy. 2010;17(4):388\u201399.","journal-title":"Drugs Educ Prev Policy"},{"issue":"2","key":"352_CR31","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1093\/jurban\/jtg032","volume":"80","author":"KH Seal","year":"2003","unstructured":"Seal KH, Downing M, Kral AH, Singleton-Banks S, Hammond JP, Lorvick J, et al. Attitudes about prescribing take-home naloxone to injection drug users for the management of heroin overdose: a survey of street-recruited injectors in the San Francisco Bay Area. J Urban Health. 2003;80(2):291\u2013301.","journal-title":"J Urban Health"},{"issue":"2","key":"352_CR32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.drugpo.2008.02.004","volume":"20","author":"SG Sherman","year":"2009","unstructured":"Sherman SG, Gann DS, Tobin KE, Latkin CA, Welsh C, Bielenson P. \u201cThe life they save may be mine\u201d: diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy. 2009;20(2):137\u201342.","journal-title":"Int J Drug Policy"},{"issue":"7044","key":"352_CR33","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/bmj.312.7044.1435","volume":"312","author":"J Strang","year":"1996","unstructured":"Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: the case for take-home naloxone. BMJ. 1996;312(7044):1435\u20136.","journal-title":"BMJ."},{"issue":"3","key":"352_CR34","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.drugpo.2009.01.003","volume":"21","author":"KD Wagner","year":"2010","unstructured":"Wagner KD, Valente TW, Casanova M, Partovi SM, Mendenhall BM, Hundley JH, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy. 2010;21(3):186\u201393.","journal-title":"Int J Drug Policy"},{"key":"352_CR35","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.drugpo.2017.09.015","volume":"51","author":"SC Heavey","year":"2018","unstructured":"Heavey SC, Chang YP, Vest BM, Collins RL, Wieczorek W, Homish GG. \u2018I have it just in case\u2019 \u2014 naloxone access and changes in opioid use behaviours. Int J Drug Policy. 2018;51:27\u201335.","journal-title":"Int J Drug Policy"},{"key":"352_CR36","unstructured":"National Institute on Drug Abuse. Alaska opioid summary. Washington, D.C.: US Department of Health and Human Services, National Institutes of Health; 2019. Available from: https:\/\/www.drugabuse.gov\/node\/pdf\/21946\/alaska-opioid-summary"},{"issue":"1","key":"352_CR37","first-page":"10","volume":"61","author":"L Paulozzi","year":"2012","unstructured":"Paulozzi L, Franklin G, Kerlikowske R, Jones C, Ghiya N, Popovic T. CDC grand rounds: prescription drug overdoses - a U.S. epidemic. Morbid Mortal Wkly. 2012;61(1):10\u20133.","journal-title":"Morbid Mortal Wkly"},{"issue":"10","key":"352_CR38","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1001\/jamasurg.2017.2230","volume":"152","author":"HK Mell","year":"2017","unstructured":"Mell HK, Mumma SN, Hiestand B, Carr BG, Holland T, Stopyra J. Emergency medical services response times in rural, suburban, and urban areas. JAMA Surg. 2017 Oct;152(10):983\u20134.","journal-title":"JAMA Surg"},{"key":"352_CR39","volume-title":"Legal interventions to reduce overdose mortality in Alaska","author":"The Network for Public Health Law","year":"2016","unstructured":"The Network for Public Health Law. Legal interventions to reduce overdose mortality in Alaska. 2016. Available from: https:\/\/www.networkforphl.org\/_asset\/tvklav\/Alaska-Overdose-Prevention-Fact-Sheet.pdf."},{"key":"352_CR40","unstructured":"U.S. Census Bureau. Alaska, 2010: population and housing unit counts. Washington, D.C.: US Department of Commerce, Economics and Statistics Administration; 2012. Available from: https:\/\/www.census.gov\/prod\/cen2010\/cph-2-3.pdf."},{"key":"352_CR41","volume-title":"The coding manual for qualitative researchers","author":"J Salda\u00f1a","year":"2016","unstructured":"Salda\u00f1a J. The coding manual for qualitative researchers. 3rd ed. London: Sage; 2016.","edition":"3"},{"key":"352_CR42","volume-title":"Qualitative data analysis: a methods sourcebook","author":"M Miles","year":"2014","unstructured":"Miles M, Huberman AM, Salda\u00f1a J. Qualitative data analysis: a methods sourcebook. 3rd ed. Thousand Oaks: Sage; 2014.","edition":"3"},{"key":"352_CR43","volume-title":"The discovery of grounded theory: strategies for qualitative research","author":"BG Glaser","year":"1967","unstructured":"Glaser BG, Strauss AL. The discovery of grounded theory: strategies for qualitative research. Chicago: Aldine; 1967."},{"issue":"4","key":"352_CR44","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/add.14510","volume":"114","author":"J Neale","year":"2019","unstructured":"Neale J, Brown C, Campbell ANC, Jones JD, Metz VE, Strang J, et al. How competent are people who use opioids at responding to overdoses? Qualitative analyses of actions and decisions taken during overdose emergencies. Addiction. 2019;114(4):708\u201318.","journal-title":"Addiction."},{"key":"352_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2016.08.006","volume":"71","author":"KE Dunn","year":"2016","unstructured":"Dunn KE, Barrett FS, Yepez-Laubach C, Meyer AC, Hruska BJ, Petrush K, et al. Opioid overdose experience, risk behaviors, and knowledge in drug users from a rural versus an urban setting. J Subst Abus Treat. 2016;71:1\u20137.","journal-title":"J Subst Abus Treat"},{"issue":"Suppl","key":"352_CR46","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.2105\/AJPH.2014.302520","volume":"105","author":"M Faul","year":"2015","unstructured":"Faul M, Dailey MW, Sugerman DE, Sasser SM, Levy B, Paulozzi LJ. Disparity in naloxone administration by emergency medical service providers and the burden of drug overdose in US rural communities. Am J Public Health. 2015;105(Suppl):e26\u201332.","journal-title":"Am J Public Health"},{"key":"352_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.addbeh.2018.03.004","volume":"86","author":"X Zhang","year":"2018","unstructured":"Zhang X, Marchand C, Sullivan B, Klass EM, Wagner KD. Naloxone access for emergency medical technicians: an evaluation of a training program in rural communities. Addict Behav. 2018;86:79\u201385.","journal-title":"Addict Behav"},{"issue":"4","key":"352_CR48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/dar.12680","volume":"37","author":"PM Dietze","year":"2018","unstructured":"Dietze PM, Draper B, Olsen A, Chronister KJ, van Beek I, Lintzeris N, et al. Does training people to administer take-home naloxone increase their knowledge? Evidence from Australian programs. Drug Alcohol Rev. 2018;37(4):472\u20139.","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"352_CR49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/10826084.2015.1108339","volume":"51","author":"FD Vigna-Taglianti","year":"2016","unstructured":"Vigna-Taglianti FD, Burroni P, Mathis F, Versino E, Beccaria F, Rotelli M, et al. Gender differences in heroin addiction and treatment: results from the VEdeTTE cohort. Subst Use Misuse. 2016;51(3):295\u2013309.","journal-title":"Subst Use Misuse"},{"issue":"3","key":"352_CR50","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.drugalcdep.2004.02.001","volume":"74","author":"CA Hernandez-Avila","year":"2004","unstructured":"Hernandez-Avila CA, Rounsaville BJ, Kranzler HR. Opioid-, cannabis- and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend. 2004;74(3):265\u201372.","journal-title":"Drug Alcohol Depend"},{"key":"352_CR51","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/1471-2458-14-440","volume":"14","author":"L Gjersing","year":"2014","unstructured":"Gjersing L, Bretteville-Jensen AL. Gender differences in mortality and risk factors in a 13-year cohort study of street-recruited injecting drug users. BMC Public Health. 2014;14:440.","journal-title":"BMC Public Health"},{"key":"352_CR52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugpo.2017.09.010","volume":"50","author":"AD Latimore","year":"2017","unstructured":"Latimore AD, Bergstein RS. \u201cCaught with a body\u201d yet protected by law? Calling 911 for opioid overdose in the context of the Good Samaritan Law. Int J Drug Policy. 2017;50:82\u20139.","journal-title":"Int J Drug Policy"},{"key":"352_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.socscimed.2017.03.013","volume":"180","author":"R Faulkner-Gurstein","year":"2017","unstructured":"Faulkner-Gurstein R. The social logic of naloxone: peer administration, harm reduction, and the transformation of social policy. Soc Sci Med. 2017;180:20\u20137.","journal-title":"Soc Sci Med"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0352-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-019-0352-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0352-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,8]],"date-time":"2021-01-08T00:59:41Z","timestamp":1610067581000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-019-0352-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,9]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1186\/s12954-019-0352-0","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,9]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was reviewed and approved by the University of Alaska\u2019s Institutional Review Board as research with human subjects (reference number 1164256). All participants provided informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. Individual quotes are not identifiable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}